Biotech Showcase, along with its family of events, Seed Showcase and TechBio Showcase, is a dedicated investor conference designed to provide private and micro-mid-cap biotechnology companies with the opportunity to present to and connect with investors and biopharmaceutical executives. With a roster of over 400 carefully selected presenting companies from across the globe, ranging from seed-stage startups to established multinational corporations, encompassing diverse fields such as platform technologies, therapeutic areas, digital health, devices, and diagnostics, these events attract investors wielding over USD 400 billion in capital and motivated strategic partners within the life science ecosystem.

For the upcoming edition, Biotech Showcase will embrace a hybrid format. In-person activities will unfold from January 8–10, 2024, at the Hilton San Francisco Union Square in San Francisco, California. Following this, the virtual components will take place during the subsequent week, from January 16–17, 2024, hosted on the partneringONE platform—an all-in-one digital experience that seamlessly combines both aspects of the event.

Learn More